No black box warning on record for Cardamyst

As of the latest FDA labeling reviewed, Cardamyst (ETRIPAMIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cardamyst medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Syncope: May cause dizziness and/or syncope, especially in patients with a history of syncope. Administer in a sitting position ( 5.1 ). 5.1 Syncope Related to Hemodynamic Effects Because of effects on blood pressure, heart rate, and cardiac conduction, CARDAMYST may cause dizziness and/or syncope, especially in patients with a history of syncope and high-grade AV block

No black box warning on record for Cardamyst

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Syncope: May cause dizziness and/or syncope, especially in patients with a history of syncope. Administer in a sitting position ( 5.1 ). 5.1 Syncope Related to Hemodynamic Effects Because of effects on blood pressure, heart rate, and cardiac conduction, CARDAMYST may cause dizziness and/or syncope, especially in patients with a history of syncope and high-grade AV block

Cardamyst Black Box Warning

No black box warning on record for Cardamyst

Other warnings & precautions

Cardamyst Black Box Warning

No black box warning on record for Cardamyst

Other warnings & precautions